Gut microbiota-derived gamma-aminobutyric acid from metformin treatment reduces hepatic ischemia/reperfusion injury through inhibiting ferroptosis
eLife · 2024
DOI: 10.7554/elife.89045 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Fangyan Wang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Ischemia/Reperfusion Injury, School of Basic Medical Science, Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Metformin, Gastrointestinal Microbiome, Ferroptosis, Reperfusion Injury. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang University Student Science and Technology Innovation Activity Plan, Zhejiang Province Public Welfare Technology Application Research Project, Suzhou Inhale Pharma Co, Ltd.
Abstract (Originalsprache)
Hepatic ischemia/reperfusion injury (HIRI) is a common and inevitable factor leading to poor prognosis in various liver diseases, making the outcomes of current treatments in clinic unsatisfactory. Metformin has been demonstrated to be beneficial to alleviate HIRI in recent studies, however, the underpinning mechanism remains unclear. In this study, we found metformin mitigates HIRI-induced ferroptosis through reshaped gut microbiota in mice, which was confirmed by the results of fecal microbiota transplantation treatment but showed the elimination of the beneficial effects when gut bacteria were depleted using antibiotics. Detailedly, through 16S rRNA and metagenomic sequencing, we identified that the metformin-reshaped microbiota was characterized by the increase of gamma-aminobutyric acid (GABA) producing bacteria. This increase was further confirmed by the elevation of GABA synthesis key enzymes, glutamic acid decarboxylase and putrescine aminotransferase, in gut microbes of metformin-treated mice and healthy volunteers. Furthermore, the benefit of GABA against HIRI-induced ferroptosis was demonstrated in GABA-treated mice. Collectively, our data indicate that metformin can mitigate HIRI-induced ferroptosis by reshaped gut microbiota, with GABA identified as a key metabolite.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Ischemia/Reperfusion Injury, School of Basic Medical Science, Wenzhou Medical University, Wenzhou, China.
- Nottingham Ningbo China Beacons of Excellence Research and Innovation Institute, The University of Nottingham Ningbo, Ningbo, China.
- Suzhou Inhal Pharma Co., Ltd., Suzhou, China.
- Wenzhou Key Laboratory of Sanitary Microbiology, Wenzhou Medical University, Wenzhou, China.
- Department of Gastroenterology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
- Medical School of Ningbo University, Ningbo University, Ningbo, China.
ORCID-Profile: Fangyan Wang, Xiujie Liu, Wantie Wang
Förderung
- Zhejiang University Student Science and Technology Innovation Activity Plan
- Zhejiang Province Public Welfare Technology Application Research Project
- Suzhou Inhale Pharma Co, Ltd
- Zhejiang Xiaolun Intelligent Manufacturing Co, Ltd
Zitieren
APA
Wang, F., Liu, X., Huang, F., Zhou, Y., Wang, X., Song, Z., Wang, S., Wang, X., Shi, D., Ruan, G., Ji, X., Zhang, E., Tan, Z., Ye, Y., Wang, C., Zhu, J., & Wang, W. (2024). Gut microbiota-derived gamma-aminobutyric acid from metformin treatment reduces hepatic ischemia/reperfusion injury through inhibiting ferroptosis. eLife. https://doi.org/10.7554/elife.89045
Vancouver
Wang F, Liu X, Huang F, Zhou Y, Wang X, Song Z, et al. Gut microbiota-derived gamma-aminobutyric acid from metformin treatment reduces hepatic ischemia/reperfusion injury through inhibiting ferroptosis. eLife. 2024. doi:10.7554/elife.89045
BibTeX
@article{Wang2024,
author = {Wang, Fangyan and Liu, Xiujie and Huang, Furong and Zhou, Yan and Wang, Xinyu and Song, Zhengyang and Wang, Sisi and Wang, Xiaoting and Shi, Dibang and Ruan, Gaoyi and Ji, Xiawei and Zhang, Eryao and Tan, Zenglin and Ye, Yuqing and Wang, Chuang and Zhu, Jesse and Wang, Wantie},
title = {Gut microbiota-derived gamma-aminobutyric acid from metformin treatment reduces hepatic ischemia/reperfusion injury through inhibiting ferroptosis},
journal = {eLife},
year = {2024},
doi = {10.7554/elife.89045}
}
EUVIMED